Interview with Dr. Justin Berk on starting patients recently released from incarceration on treatment for opioid use disorder. (10:59)Download Federal and state initiatives designed to increase access to buprenorphine have focused nearly exclusively on physicians and other prescribers. Yet their success depends entirely on whether pharmacists dispense buprenorphine to patients who present with a prescription.
No takes yet. Share an insight, caveat, or question.
Cooper et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: